Remove 2012 Remove Cannabinoids Remove Clinical Trials Remove History
article thumbnail

Debunked: Study Linking Cannabis Use and Metabolic Syndrome

Freedom Leaf

Researchers at the Georgia State University School of Public Health assessed the association between cannabis use duration and MetS in a cohort of 3,051 adults who participated in the National Health and Nutrition Examination Survey (NHANES) in 2011-2012. If you enjoyed this Freedom Leaf article, subscribe to the magazine today!

article thumbnail

Relieve the Excruciating Symptoms of IBD and IBS with Medical Cannabis

Veriheal

The exact causes of IBD are still unknown but risk factors such as age, race, family history, cigarette smoking, anti-inflammatory as well as environmental factors such as where the individual lives. More research and clinical trials are needed to fully understand how cannabinoids help those suffering from GI pathologies.

Digestion 123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98
article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

Brief history of ALS. Exploring the available research on ALS and cannabinoids. The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. How to Get a Medical Marijuana Prescription in Canada.

Strains 94
article thumbnail

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64
article thumbnail

Green Relief - Untitled Article

Green Relief

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

The Cannabis sativa plant has an incredibly multi-layered, rich, and versatile history of human uses for food and fibre, as well as recreational, and religious and spiritual purposes throughout the world (McPartland and Hegman 2018 ; Aldrich 1997 ; Touw 1981 ; Li 1974 ; Bonini et al. years (Atakan 2012 ). 2016 ; Sznitman et al.